Telehealth Subscription Fraud: The Cancellation That Does Not Stop the Charge

Telehealth subscription fraud can involve misleading treatment promises, recurring charges the customer did not agree to, or cancellation barriers that keep the money coming. Patients pay for promised care, then face charges they never authorized or cannot stop. The business controls the offer, the charge and the way out. If you work in billing, product design, clinical operations or customer support, you may see where those promises part company with what the system actually does. The important connection can run from an advertisement to an intake questionnaire, a prescription, a renewal and a cancellation request that never stops the next charge.

What Does a Telehealth Subscription Buy?

A telehealth subscription can buy access, a consultation, medication, lab work or continuing support. The price, the clinical service and the shipment can follow different schedules.

Hims & Hers describes that business in its annual report for 2025. Customers select a shipment schedule or treatment term, and the company bills them on that recurring schedule. The filing says customers can cancel or pause subscriptions under the company’s terms. It also describes prepaid offerings in which the customer pays upfront and receives later shipments.

The filing separates product delivery, consultations and continuing support: product revenue generally begins at transfer to the carrier, consultation revenue when the service occurs, and support revenue over the contract term. Money collected for undelivered products or services remains deferred revenue until the company fulfills the promise.

The organizations can differ too. The filing describes physician-owned medical groups supplying clinical services while Hims & Hers supplies billing, collection, technology and customer support. For an insider, that makes the management agreement and the billing instructions relevant alongside the clinical chart. The company handling the cancellation may be different from the professional treating the patient.

When the Monthly Price Does Not Match the Promise

NextMed’s December 2025 final Federal Trade Commission order regulates what the company tells customers its telehealth price includes: consultations, appointments, lab work and treatment. The order also addresses evidence for typical results, fabricated reviews, consent, recurring billing and cancellation.

For someone inside the sales operation, fake reviews and claims about typical results belong beside the price representations. We connect the versions of those materials with the subscription terms, the people who approved the offer and the complaints that reached the company.

Hims & Hers Consultation and Billing Allegations

A July 2026 complaint by the Federal Trade Commission, California and Utah alleges problems with Hims & Hers consultation promises, the timing of intake and charges, treatment approval, refills, cancellation and advertising disclosures. The complaint puts the order of events at the center of the inquiry. What offer did the customer see? What did completing the questionnaire authorize? When did the practitioner decide whether to approve treatment, and when did the charge occur? An employee who understands the rules behind those transitions can explain much more than a monthly billing total.

How Intake Becomes a Recurring Charge

Recurring prescriptions can make the decision to continue treatment part of the revenue model. The initial questionnaire, the prescribing decision and the follow-up arrangement deserve to be examined together. In its criminal non-prosecution agreement, Cerebral admitted using prescribing targets.

The subscription ledger shows when the business charged again. The clinical and staffing records show how it kept the treatment going. We examine the connection between them, including what happened after a provider declined to prescribe.

Cancellation Is Part of the Product

Cancellation records show whether the business honored the customer’s decision to stop paying. The request, the account status, the next charge and any refund belong together. A cancellation option on a screen says little about how the request moved through the billing system.

The federal consumer complaint against Cerebral alleged problems involving subscription cancellation as well as privacy and data security. In its May 8, 2025 refund announcement, the Federal Trade Commission said it was sending more than $5 million to 40,249 consumers affected by cancellation problems.

For employees who see telehealth cancellation requests ignored, internal records can connect the customer’s request to the decision that left the subscription active. Request timestamps, cancellation paths, refund decisions and continuing access show how the process worked. We compare them with the next billing event and the terms the customer accepted. That is how a support complaint becomes evidence about a recurring business practice.

Telemedicine Added to a Health Plan Sale

The Federal Trade Commission’s Benefytt complaint alleged deceptive health-plan sales involving unwanted telemedicine add-ons and continuing charges. Its Assurance IQ complaint likewise alleged misleading sales scripts, coverage representations and charges without informed consent.

A telehealth patient access subscription bundled with insurance makes the enrollment record particularly important. The sales script, the product description and the consent record show what the buyer understood they were purchasing. The recurring bill shows which products the seller kept charging for. Those sales records can be held far from the clinicians who supply the care.

When Support Ends but Installments Continue

SmileDirectClub supplies a different service-continuity problem. A signed November 2024 agreement with the New York Attorney General’s office addressed installment collection after promised monitoring and support ceased.

The payment obligation and the promised continuing service had become separated. For a subscription or installment business, the useful comparison is the support promised for the treatment period, when that support ended and what collection activity continued. A financing record can carry part of the story that the appointment record cannot.

Who Paid for the Subscription and the Care?

A consumer can pay for a subscription, an employer or plan can buy access, and a government program can pay for a covered health care service. The contract identifies what each payment buys.

Hims & Hers said in its annual report that it accepted payments only from customers in the United States, rather than from government healthcare programs or insurers. The Cerebral whistleblower complaint, by contrast, alleged federal-program reimbursement for prescriptions, subscription services and appointments connected to the alleged prescribing incentives. Each account needs its own payer and its own representation.

For a telehealth benefit purchased by an employer or plan, we examine the access commitment, benefit terms and invoice against what the vendor delivered. The inquiry follows the promised service and the unit the buyer agreed to fund. An access contract and a contract paying for completed visits ask different things of the vendor.

The government-payment question can reach beyond the monthly fee to prescriptions and appointments. The False Claims Act provides the whistleblower route for a qualifying case involving false government claims. Cerebral’s cancellation refunds went to consumers, while a whistleblower reward is a share of a government recovery in a whistleblower case. We identify the payment and the false representation with you before assessing that opportunity. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

What Evidence Is Needed to Prove Fraud?

The useful evidence connects the sales promise to the authorization, the charge and the care or access delivered. Internal records add the decisions behind those events: who chose the offer, how the billing rule operated and what happened when customers objected.

The proof sits across sales, billing and clinical systems, from the consent screen to the prescribing rule and the attempted cancellation. We connect those records with you to show how the company’s decisions kept charges or prescriptions coming.

We work with your knowledge of how these records fit together. A product employee may understand the screen that triggered enrollment. A billing employee may understand the renewal rule. A clinician may know what happened when treatment was declined. Their views meet at the same customer transaction.

Treatment Questionnaires and Advertising Disclosures

When a telehealth platform shares treatment questionnaire information with advertisers, the data flow adds another issue to the subscription sale. BetterHelp’s final Federal Trade Commission order addresses treatment, account and questionnaire information used for targeting. Consent screens, advertising software configurations and recipient logs can show what information moved and what the customer was told.

Monument’s entered telehealth privacy order suspended a $2.5 million civil penalty on financial conditions. Its restrictions addressed tracking disclosures and HIPAA representations. For the employee, the subscription charge and the advertising disclosure each have a transaction trail worth understanding.

You Know What Kept the Charges Coming

If you can connect a treatment promise to a recurring charge, a prescribing target or a cancellation decision, speak with our whistleblower experts about the subscription business you know. We build the case with you around the company’s decisions and the payments they produced, and bring in healthcare fraud whistleblower lawyers who understand subscription billing and prescribing incentives. Our whistleblower experts guide the strategy with you from the first conversation through the case.